Apoptosis-Related (Survivin, Bcl-2), Tumor Suppressor Gene (p53), Proliferation (Ki-67), and Non-Receptor Tyrosine Kinase (Src) Markers Expression and Correlation With Clinicopathologic Variables in 60 Thymic Neoplasms

生存素 胸腺癌 医学 酪氨酸激酶 病理 阶段(地层学) 胸腺瘤 精确检验 原癌基因酪氨酸蛋白激酶Src 免疫组织化学 肿瘤科 内科学 癌症研究 受体 生物 癌症 古生物学
作者
Thaer Khoury,Ainan Arshad,Paul N. Bogner,Nithya Ramnath,Shaozeng Zhang,Rameela Chandrasekhar,Gregory E. Wilding,Sadir Alrawi,Dongfeng Tan
出处
期刊:Chest [Elsevier BV]
卷期号:136 (1): 220-228 被引量:27
标识
DOI:10.1378/chest.08-2482
摘要

Our objective was to investigate the expression of survivin, Bcl-2, p53, Ki-67, and Src in thymic neoplasms and analyze their interrelationship with clinicopathologic variables.A series of 60 thymic neoplasms was reviewed and classified according to the World Health Organization (WHO) scheme. Key clinical information, including Masaoka stage, recurrence-free survival (RFS), and overall survival (OS) was obtained. The percentage and staining intensity of listed markers were recorded. The correlation of markers and clinicopathologic variables was statistically analyzed using the Fisher exact test and log-rank test.There were 7 type A, 15 type AB, 8 type B1, 5 type B2, 17 type B3 thymomas, and 8 thymic carcinomas. Seven patients (11.7%) died of the disease. Tumors recurred in eight patients (13.3%). Although p53 expression alone was found to be correlated with RFS with borderline significance (p = 0.056), patients with Src-positive and p53-positive coexpression had a shorter OS time than the other groups (p < 0.008). Cytoplasmic expression of survivin was present in 5 of 60 thymic neoplasms (8.3%), 4 of which were thymic carcinomas that all recurred.Regardless of WHO type and/or tumor stage, although p53 expression may predict recurrence in thymomas, p53 and Src coexpression can predict shorter OS, and cytoplasmic localization of survivin may predict recurrence in thymic carcinoma. These findings make thymic tumors a prime target for newly developed anti-Src and anti-survivin therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xianyaoz完成签到 ,获得积分0
2秒前
杨远杰完成签到,获得积分10
3秒前
蓝桉完成签到 ,获得积分10
3秒前
JuliaWang完成签到 ,获得积分10
10秒前
无限的含羞草完成签到,获得积分10
11秒前
八二力完成签到 ,获得积分10
15秒前
韭菜发布了新的文献求助10
18秒前
情怀应助科研通管家采纳,获得30
21秒前
water应助科研通管家采纳,获得10
21秒前
JamesPei应助科研通管家采纳,获得10
21秒前
2012csc完成签到 ,获得积分0
23秒前
风清扬应助韭菜采纳,获得10
24秒前
WSY完成签到 ,获得积分10
25秒前
虞无声发布了新的文献求助10
26秒前
执着新蕾完成签到,获得积分10
28秒前
Vivian完成签到 ,获得积分10
31秒前
666完成签到 ,获得积分10
33秒前
38秒前
量子星尘发布了新的文献求助10
41秒前
蔡从安完成签到,获得积分10
41秒前
奥雷里亚诺完成签到 ,获得积分10
41秒前
不呆完成签到 ,获得积分10
42秒前
Cheung2121发布了新的文献求助30
42秒前
画龙完成签到,获得积分10
43秒前
韭菜完成签到,获得积分20
44秒前
Owen应助Cheung2121采纳,获得10
47秒前
爱学习的小李完成签到 ,获得积分10
52秒前
若水完成签到 ,获得积分10
52秒前
SYLH应助tian采纳,获得10
52秒前
脑洞疼应助tian采纳,获得10
53秒前
Ava应助tian采纳,获得10
53秒前
领导范儿应助tian采纳,获得10
53秒前
桐桐应助tian采纳,获得10
53秒前
乐乐应助tian采纳,获得10
53秒前
乐乐应助tian采纳,获得10
53秒前
wbscz应助tian采纳,获得10
53秒前
ding应助tian采纳,获得10
53秒前
53秒前
研友_LBRPOL完成签到,获得积分10
55秒前
gao完成签到 ,获得积分10
56秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022